6:24 PM
 | 
Mar 22, 2016
 |  BC Extra  |  Financial News

Syntimmune raises second series A tranche

Syntimmune Inc. (New York, N.Y.) raised $10 million in the second tranche of a planned $26 million series A round co-led by Apple Tree Partners and the Baxalta Ventures arm of

Read the full 141 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >